CD5 knockout using CRISPR boosts CAR T cell therapy efficacy
CAR T cells are T cells designed to attack specific targets on cancer cells. They have produced remarkable results in certain patients with blood cancers. However, they have not worked well against other cancers, particularly solid tumor cancers such as pancreatic cancer, prostate cancer, and melanoma. The researchers looked for techniques to increase the effectiveness […]